Filtros de búsqueda

Lista de obras de

32P-incorporation PCR for the detection of rearrangements at the TCR-gamma locus

artículo científico publicado en 1996

A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR.

artículo científico publicado en 2013

A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML.

artículo científico publicado en 1990

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study

artículo científico publicado en 2019

A cluster of three cases of aplastic anaemia in children

artículo científico publicado en 1988

A comparison of ISDN and home broadband transmission in delivering home support for infants with major congenital heart disease.

artículo científico publicado en 2013

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

artículo científico publicado en 2010

A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue.

artículo científico publicado en 2014

A gene expression signature for high-risk multiple myeloma.

artículo científico publicado en 2012

A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment.

artículo científico publicado en 2011

A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.

artículo científico publicado en 2004

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

artículo científico publicado en 2019

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

scientific article published on 01 January 2020

A modified method for whole exome resequencing from minimal amounts of starting DNA

artículo científico publicado en 2012

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

artículo científico publicado en 2014

A molecular study of the t(4;14) in multiple myeloma.

artículo científico publicado en 2002

A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis

scientific article published on 01 September 2018

A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex

artículo científico publicado en 2014

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

artículo científico publicado en 2011

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

artículo científico publicado en 1997

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

scientific article published on 21 August 2017

A polymorphism in the 3′ UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma

artículo científico publicado en 2010

A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide

artículo científico publicado en 2012

A single tube nested RT-PCR for detecting the common myeloid specific chromosomal translocations

artículo científico publicado en 1995

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma

artículo científico publicado en 2007

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma ⬇️

artículo científico publicado en 2015

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

artículo científico publicado en 2010

Active multiple myeloma suppresses and typically eliminates coexisting MGUS.

artículo científico publicado en 2017

Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.

artículo científico publicado en 2011

Advances in the biology and treatment of myeloma.

artículo científico publicado en 1999

Aetiology of bone disease and the role of bisphosphonates in multiple myeloma ⬇️

artículo científico publicado el 1 de mayo de 2003

Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma

artículo científico publicado en 2005

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia.

artículo científico publicado en 2002

Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology

artículo científico publicado en 2002

Allele imbalance at tumour suppressor loci during the indolent phase of follicle centre cell lymphoma.

artículo científico publicado en 1996

Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk

scientific article published on 01 January 1997

Aminopeptidase inhibition as a targeted treatment strategy in myeloma.

artículo científico publicado en 2009

An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation

scientific article published on 01 January 2000

An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia

artículo científico publicado en 2011

An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics

scientific article published on 14 October 2020

An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents.

artículo científico publicado en 2003

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of

artículo científico publicado en 2007

An update on drug combinations for treatment of myeloma.

scientific article published on January 2008

Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides direct evidence that thymic T-cell production declines with age.

artículo científico publicado en 1999

Antibody-based targeting of BCMA in multiple myeloma

scientific article published on 01 February 2020

Antimyeloma activity of heat shock protein-90 inhibition.

artículo científico publicado en 2005

Antitumor Effects and Anticancer Applications of Bisphosphonates ⬇️

artículo científico publicado el 1 de octubre de 2010

Assessing response of myeloma bone disease with diffusion-weighted MRI.

artículo científico publicado en 2012

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach.

artículo científico publicado en 2017

Assessment of IgH PCR strategies in multiple myeloma.

artículo científico publicado en 1996

Association between non-Hodgkin lymphoma and haplotypes in the TNF region

artículo científico publicado en 2006

Association of metabolic gene polymorphisms with tobacco consumption in healthy controls

artículo científico publicado en 2004

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

artículo científico publicado en 2019

Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up

artículo científico publicado en 2001

Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.

artículo científico publicado en 1998

B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures

artículo científico publicado en 2009

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors

artículo científico publicado en 1998

BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.

artículo científico publicado en 1995

BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma

scientific article published on 27 January 2020

Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes

artículo científico publicado en 2019

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

artículo científico publicado en 2011

Benzene and the hemopoietic stem cell.

artículo científico publicado en 2005

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

scientific article published on 24 February 2017

Binding of monoclonal antibody to CD16 causes calcium mobilization in large granular lymphocytes but inhibits NK killing

artículo científico publicado en 1989

Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma.

artículo científico publicado en 2013

Biology and treatment of myeloma

artículo científico

Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple Myeloma.

artículo científico publicado en 2017

Bone marrow and peripheral blood stem cell transplantation for malignancy

Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials

artículo científico publicado en 2020

Both paroxysmal nocturnal hemoglobinuria (PNH) type II cells and PNH type III cells can arise from different point mutations involving the same codon of the PIG-A gene

artículo científico publicado en 1997

Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered

artículo científico publicado en 1992

CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy

artículo científico publicado en 2006

CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.

artículo científico publicado en 2002

Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?

scientific article published on February 2011

Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.

artículo científico publicado en 2017

Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group

artículo científico publicado el 1 de enero de 1997

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials ⬇️

artículo científico publicado en 2018

Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisation

scientific article published on 01 October 2008

Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.

artículo científico publicado en 2013

Characterization of a novel mouse model of multiple myeloma and its use in preclinical therapeutic assessment

artículo científico publicado en 2013

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

artículo científico publicado en 1997

Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

artículo científico publicado en 1998

Cleavage of BLOC1S1 mRNA by IRE1 Is Sequence Specific, Temporally Separate from XBP1 Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum Stress

artículo científico publicado en 2015

Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.

artículo científico publicado en 2017

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

artículo científico publicado en 2018

Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis

artículo científico publicado en 2011

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

artículo científico publicado en 2015

Clinicopathological correlates of IgM paraproteinemias.

artículo científico publicado en 2000

Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients

scientific article published on 07 February 2019

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

artículo científico publicado en 2016

Clonality analysis for antigen receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936.

artículo científico publicado en 2003

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations

artículo científico publicado en 2014

Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy

artículo científico publicado en 2007

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

artículo científico publicado en 2018

Common gastrointestinal diseases and anorexia nervosa in British dietitians

scientific article published on 01 May 1983

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

scientific journal article

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

scientific journal article

Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL.

artículo científico publicado en 1997

Controversies surrounding the clonogenic origin of multiple myeloma

artículo científico publicado en 2000

Correction: A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA.

artículo científico publicado en 2012

Cost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective.

artículo científico publicado en 2012

Could DNA methylation become a useful measure for multiple myeloma prognoses?

artículo científico publicado en 2011

Current and potential epigenetic targets in multiple myeloma.

artículo científico publicado en 2014

Current multiple myeloma treatment strategies with novel agents: a European perspective

scientific article published on 19 January 2010

Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.

artículo científico publicado en 2011

Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma

artículo científico publicado en 2006

Deletions of CDKN2C in multiple myeloma: biological and clinical implications

artículo científico publicado en 2008

Demonstration of changes in plasma cell subsets in multiple myeloma

artículo científico publicado en 2007

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

artículo científico publicado en 2003

Designing Evolutionary Based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma

artículo científico publicado en 2020

Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML

artículo científico publicado en 1997

Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia.

artículo científico publicado en 1995

Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection.

artículo científico publicado en 1996

Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse

artículo científico publicado en 1991

Diagnosis and monitoring for light chain only and oligosecretory myeloma using serum free light chain tests. ⬇️

artículo científico publicado en 2017

Diagnostic approaches to acute promyelocytic leukaemia.

artículo científico publicado en 1999

Differential RNA splicing as a potentially important driver mechanism in multiple myeloma

artículo científico publicado en 2020

Differential transcription factor occupancy but evolutionarily conserved chromatin features at the human and mouse M-CSF (CSF-1) receptor loci.

artículo científico publicado en 2003

Differentiation stage of myeloma plasma cells: biological and clinical significance.

artículo científico publicado en 2016

Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients.

artículo científico publicado en 2015

Distinct promoter methylation profile reveals spatial epigenetic heterogeneity in 2 myeloma patients with multifocal extramedullary relapses

artículo científico publicado en 2018

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

scientific article published on 01 January 1999

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

artículo científico publicado en 2016

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma.

scientific article published on 16 September 2016

Effects of bone-targeted agents on cancer progression and mortality.

artículo científico publicado en 2012

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

artículo científico publicado en 2011

Efficacy and outcome of autologous transplantation in rare myelomas.

artículo científico publicado en 2010

Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: a pilot study

artículo científico publicado en 1997

Enhancing cancer clonality analysis with integrative genomics.

artículo científico publicado en 2015

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

artículo científico publicado en 2014

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

artículo científico publicado en 2010

European perspective on multiple myeloma treatment strategies in 2014

artículo científico publicado en 2014

Evolution of treatment strategies in multiple myeloma.

artículo científico publicado en 1998

Evolutionary biology of high-risk multiple myeloma

artículo científico publicado en 2017

Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein.

artículo científico publicado en 2007

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

artículo científico publicado en 2014

Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.

artículo científico publicado en 2017

FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells.

artículo científico publicado en 1999

FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2000

FRAX is a robust predictor of baseline vertebral fractures in multiple myeloma patients

scientific article published on 19 September 2018

Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.

artículo científico publicado en 2011

False-positive results with PCR to detect leukaemia-specific transcript.

artículo científico publicado en 1990

Fenestration closure with Amplatzer Duct Occluder II in patients after total cavo-pulmonary connection

artículo científico publicado en 2016

First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana

artículo científico publicado en 2011

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

artículo científico publicado en 2010

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

artículo científico publicado en 2002

Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120).

artículo científico publicado en 2016

Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma.

artículo científico publicado en 1996

Further analyses of the Myeloma IX Study

artículo científico publicado en 2011

Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies.

artículo científico publicado en 2010

Gender disparities in the tumor genetics and clinical outcome of multiple myeloma

artículo científico publicado en 2011

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

article

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism

artículo científico publicado en 2017

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

artículo científico publicado en 2008

Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology ⬇️

scholarly article by Molly Went et al published 21 December 2018 in Blood Cancer Journal

Genetic factors influencing the risk of multiple myeloma bone disease ⬇️

artículo científico publicado en 2015

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

artículo científico publicado en 2011

Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination

artículo científico publicado en 2002

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

artículo científico publicado en 2006

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.

artículo científico publicado en 2004

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci

artículo científico publicado en 2017

Genome-wide association study identifies multiple susceptibility loci for multiple myeloma ⬇️

artículo científico publicado en 2016

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma ⬇️

artículo científico publicado en 2016

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

artículo científico publicado en 2017

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

artículo científico publicado en 2016

Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance

artículo científico publicado en 2016

Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.

artículo científico publicado en 2003

Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

artículo científico publicado en 2013

Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysis

artículo científico publicado en 2015

HHV-8 and multiple myeloma in the UK

scientific article published on 01 October 1997

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.

artículo científico publicado en 2018

Haematological cancer: Optimizing the treatment of multiple myeloma

artículo científico publicado en 2014

Haematological cancer: Where are we now with the treatment of multiple myeloma?

scientific article published on 13 June 2017

Haplotypes in the tumour necrosis factor region and myeloma.

artículo científico publicado en 2005

Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma

artículo científico publicado en 2006

Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice.

artículo científico publicado en 2007

Heterogeneity in cell proliferation and expression of p53 and bcl-2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variability

scientific article published on 01 August 1995

Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myeloma

scientific article published on 06 December 2010

High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases

artículo científico publicado en 2002

High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.

artículo científico publicado en 2010

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

artículo científico publicado en 2003

High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis

article

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

artículo científico publicado en 2000

High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia

artículo científico publicado en 2011

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia.

artículo científico publicado en 2004

How are cancer associated genes activated or inactivated?

artículo científico publicado en 1992

How to use new biology to guide therapy in multiple myeloma.

artículo científico publicado en 2012

Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress

artículo científico publicado en 2013

Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

scientific article published on 19 April 2017

Hyperhaploid karyotypes in multiple myeloma.

artículo científico publicado en 2017

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

artículo científico publicado en 2016

IMWG consensus on maintenance therapy in multiple myeloma

artículo científico publicado en 2012

IVIG, aspirin, and Kawasaki disease

artículo científico publicado en 2003

Identification of a novel t(7;14) translocation in multiple myeloma resulting in overexpression of EGFR.

artículo científico publicado en 2013

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

scientific article published in Nature Communications

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

scientific article published on 08 June 2018

Immunoglobulin aggregation leading to Russell body formation is prevented by the antibody light chain

artículo científico publicado en 2010

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

artículo científico publicado en 2007

Immunophenotypic analysis of B cells in PNH: insights into the generation of circulating naive and memory B cells.

artículo científico publicado en 2000

Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma ⬇️

artículo científico publicado en 2015

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936

artículo científico publicado en 2006

Improved risk stratification in myeloma using a microRNA-based classifier.

artículo científico publicado en 2013

In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.

artículo científico publicado en 2001

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

artículo científico publicado en 2000

Infection Risk Associated with Daratumumab.

artículo científico publicado en 2017

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance

artículo científico publicado en 2014

Inherited genetic susceptibility to multiple myeloma

artículo científico publicado en 2013

Initial assessment of a novel delivery system (NuDEL™ ®) for the covered Cheatham-Platinum stent.

artículo científico

Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns

artículo científico publicado en 2009

Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma

artículo científico publicado en 2015

Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma

artículo científico publicado en 2006

Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma

artículo científico publicado en 2001

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

artículo científico publicado en 2014

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

artículo científico publicado en 2009

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

artículo científico publicado en 2013

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

artículo científico publicado en 2020

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials

artículo científico publicado en 2020

International uniform response criteria for multiple myeloma.

artículo científico publicado en 2006

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

artículo científico publicado en 2012

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

scientific article published on 02 July 2013

Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases

artículo científico publicado en 1992

Isotype class switching and the pathogenesis of multiple myeloma.

artículo científico publicado en 2002

Jumping translocations and high-risk myeloma

artículo científico publicado en 2014

Kinase domain activation through gene rearrangement in multiple myeloma.

artículo científico publicado en 2018

Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients

scientific article published on 01 May 2007

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2018

Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment

artículo científico publicado en 2014

Light and electron microscopic studies of cellular localization of oPL with monoclonal and polyclonal antibodies.

artículo científico publicado en 1992

Light chain-deficient mice produce novel multimeric heavy-chain-only IgA by faulty class switching

artículo científico publicado en 2009

Liposomal daunorubicin:in vitro andin vivo efficacy in multiple myeloma

artículo científico publicado en 1998

Long distance vectorette PCR (LDV PCR).

artículo científico publicado en 2002

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

artículo científico publicado en 2018

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma

artículo científico publicado en 2017

MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.

artículo científico publicado en 2018

MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.

artículo científico publicado en 2008

Maintaining therapeutic progress in multiple myeloma by integrating genetic and biological advances into the clinic

artículo científico publicado en 2018

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

artículo científico publicado en 2018

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

artículo científico publicado en 2011

Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes

article

Microsatellite instability in follicle centre cell lymphoma.

artículo científico publicado en 1996

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study

artículo científico publicado en 2013

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

artículo científico publicado en 2015

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction

artículo científico publicado en 2015

Minimal residual disease monitoring in multiple myeloma.

artículo científico publicado en 2002

Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim).

artículo científico publicado en 1996

Modern molecular diagnostics and the management of haematological malignancies.

artículo científico publicado en 1998

Molecular analysis of Philadelphia positive essential thrombocythemia

artículo científico publicado en 1989

Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis

artículo científico publicado en 1990

Molecular biology of the Philadelphia positive leukaemias.

artículo científico publicado en 1989

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

scientific article published on 01 February 2000

Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

artículo científico publicado en 2002

Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression

artículo científico publicado en 2016

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

artículo científico publicado en 2015

Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7.

artículo científico publicado en 2002

Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin

artículo científico publicado en 2011

Myeloablative therapy and bone marrow transplantation for Langerhans' cell histiocytosis

artículo científico publicado en 1994

MyelomA Genetics International Consortium

artículo científico

Myeloma: diagnosis complications and supportive care.

artículo científico publicado en 2012

NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study.

artículo científico publicado en 2001

Neutral tumor evolution in myeloma is associated with poor prognosis. ⬇️

artículo científico publicado en 2017

Non-homologous end-joining gene profiling reveals distinct expression patterns associated with lymphoma and multiple myeloma.

artículo científico publicado en 2010

Novel drugs in myeloma: harnessing tumour biology to treat myeloma.

artículo científico publicado en 2011

Optimizing protein stability in vivo

artículo científico publicado en 2009

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

artículo científico publicado en 2018

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

artículo científico publicado en 2014

Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

artículo científico publicado en 2017

Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK

artículo científico publicado en 2002

Percutaneous Closure of Post-Myocardial Infarction Ventricular Septal Defect: Patient Selection and Management

artículo científico publicado en 2012

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

artículo científico publicado en 2007

Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.

artículo científico publicado en 1996

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

artículo científico publicado en 2011

Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies.

artículo científico publicado en 2015

Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy

artículo científico publicado en 2013

Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products

artículo científico publicado el 1 de octubre de 1992

Polymerase chain reaction for detection of residual leukaemia

artículo científico publicado en 1989

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.

artículo científico publicado en 2007

Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma.

artículo científico publicado en 2003

Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia

article

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. ⬇️

artículo científico publicado en 2001

Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma.

artículo científico publicado en 2005

Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults

artículo científico publicado en 1999

Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma

article

Poor metabolizer status at the cytochrome P450 2C9 and 2D6 loci does not modulate susceptibility to therapy-related acute myeloid leukaemia

scientific article published on 01 April 2003

Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of

scientific article published on 22 January 2019

Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells

artículo científico publicado en 2017

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. ⬇️

artículo científico publicado en 2017

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells.

artículo científico publicado en 2015

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

artículo científico publicado en 2007

Proteomics and the haematologist.

artículo científico publicado en 2004

Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study ⬇️

artículo científico publicado en 2018

RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia

article

Radiolucent retractor for angiographic analysis during hybrid congenital cardiac procedures

artículo científico publicado en 2010

Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.

artículo científico publicado en 2002

Reconstructing the evolutionary history of multiple myeloma

artículo científico publicado en 2020

Reply to M. Roschewski et al.

artículo científico publicado en 2014

Reply to letters on review ‘Evolving treatment strategies for myeloma'

artículo científico publicado en 2005

Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.

artículo científico publicado en 2013

Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study. ⬇️

artículo científico publicado en 2017

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 14 October 2019

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses

artículo científico publicado en 2005

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

artículo científico publicado en 2015

Risk of multiple myeloma in a case-spouse study

artículo científico publicado en 2015

Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma

scientific article published on 13 December 2019

Role of thalidomide in the treatment of patients with multiple myeloma.

artículo científico

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

artículo científico publicado en 2016

Search for rare protein altering variants influencing susceptibility to multiple myeloma

artículo científico publicado en 2017

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. ⬇️

artículo científico publicado en 2016

Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome.

artículo científico publicado en 2014

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma

artículo científico publicado en 2018

Serum free light chains for monitoring multiple myeloma.

artículo científico publicado en 2004

Significance of residual leukaemia transcripts after bone marrow transplant for CML

artículo científico publicado en 1990

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma

article

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups.

artículo científico publicado en 2002

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

artículo científico publicado en 2017

Spontaneous remission in a patient with chronic myeloid leukaemia

artículo científico publicado en 1989

Spurious outbreak of HCV in bone-marrow recipients treated with cytomegalovirus immunoglobulin

artículo científico publicado el 21 de noviembre de 1992

Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.

artículo científico publicado en 2008

Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response ⬇️

artículo científico publicado el 11 de febrero de 2011

Sub-clonal copy number is associated with prognosis in multiple myeloma

artículo científico publicado en 2018

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

artículo científico publicado en 2018

Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE.

artículo científico publicado en 2008

Systemic blood pressure after stent management for arch coarctation implications for clinical care.

artículo científico publicado en 2013

TRUE SPECTRUM OF 14q32 TRANSLOCATIONS IN MULTIPLE MYELOMA

artículo científico publicado en 1998

Targeting bone as a therapy for myeloma.

artículo científico publicado en 2011

Targeting bone in myeloma.

artículo científico

Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma.

artículo científico publicado en 2010

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells

artículo científico publicado en 2014

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma

artículo científico publicado en 2013

The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.

artículo científico publicado en 1999

The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma

artículo científico publicado en 2018

The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. ⬇️

artículo científico publicado en 2016

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.

artículo científico publicado en 2010

The bone marrow microenvironment influences the differential chemokine receptor expression of normal and neoplastic plasma cells

scientific article published on 01 June 2005

The changing incidence of lymphoproliferative disorders in Yorkshire.

artículo científico publicado en 1998

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

artículo científico publicado en 2011

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

artículo científico publicado en 2014

The clinical value of detecting gene rearrangements in acute leukaemias.

artículo científico publicado en 1994

The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway

artículo científico publicado en 2015

The combination of cyclophosphamide, velcade and dexamethasone induces high response rates with comparable toxicity to velcade alone and velcade plus dexamethasone

artículo científico publicado en 2007

The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a

artículo científico publicado en 2006

The current landscape of multiple myeloma treatment

artículo científico publicado en 2008

The development of haematopathology laboratories: a possible model for other pathology services

scientific article published on 01 March 1998

The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.

artículo científico publicado en 2003

The diagnosis and interventional management of pulmonary arteriovenous malformations.

artículo científico publicado en 2016

The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience

artículo científico publicado en 2016

The genetic architecture of multiple myeloma.

artículo científico publicado en 2012

The genomic features associated with high-risk multiple myeloma

artículo científico publicado en 2018

The genomic landscape of plasma cells in systemic light chain amyloidosis

scientific article published on 16 November 2018

The impact of extramedullary disease at presentation on the outcome of myeloma

artículo científico publicado en 2009

The impact of intra-clonal heterogeneity on the treatment of multiple myeloma.

artículo científico

The impact of long-term lenalidomide exposure on the cellular composition of bone marrow

article

The impact of response on bone-directed therapy in patients with multiple myeloma.

artículo científico publicado en 2013

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

artículo científico publicado en 2000

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.

artículo científico publicado en 2017

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.

artículo científico publicado en 2018

The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis.

artículo científico publicado en 2010

The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody ⬇️

artículo científico publicado el 1 de diciembre de 1997

The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma

artículo científico publicado en 2011

The relationship between typical and atypical B-cell chronic lymphocytic leukemia. A comparative genomic hybridization-based study.

artículo científico publicado en 2000

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

artículo científico publicado en 2019

The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients.

artículo científico publicado en 2008

The role of second autografts in the management of myeloma at first relapse.

artículo científico publicado en 2006

The safety of pomalidomide for the treatment of multiple myeloma

artículo científico publicado en 2016

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

artículo científico publicado en 2014

The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma

artículo científico publicado en 2017

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.

artículo científico publicado en 2003

The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance

artículo científico publicado en 2010

The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies.

artículo científico publicado en 2003

The utility of newer imaging techniques as predictors of clinical outcomes in multiple myeloma.

artículo científico publicado en 2014

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

artículo científico publicado en 2017

Tobacco and the risk of acute leukaemia in adults.

artículo científico publicado en 1999

Transfection of siRNAs in multiple myeloma cell lines.

artículo científico publicado en 2010

Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.

artículo científico publicado en 2004

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

artículo científico publicado en 2014

Treatment of relapsed and refractory multiple myeloma in the era of novel agents

artículo científico publicado en 2010

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

artículo científico publicado en 2014

Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11a.

artículo científico publicado en 1998

Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application.

artículo científico publicado en 2013

Understanding the multiple biological aspects leading to myeloma

artículo científico publicado en 2014

United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma.

artículo científico publicado en 2013

United Kingdom Myeloma Forum position statement on the use of consolidation and maintenance treatment in myeloma.

artículo científico publicado en 2014

Updates to the guidelines for the diagnosis and management of multiple myeloma

artículo científico publicado en 2014

Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

artículo científico publicado en 2006

Utilizing new biology to guide treatment directions in myeloma.

artículo científico publicado en 2013

Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.

artículo científico publicado en 2000

What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?

artículo científico publicado en 2012

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

artículo científico publicado en 2015

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities

artículo científico publicado en 2021

p53 gene mutations in multiple myeloma.

artículo científico publicado en 1997

t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda